25 € Neukundenbonus + 1 Aktie gratis. Hol Dir jetzt Dein finanzen.net ZERO-Depot!

Roche Aktie

Kaufen

Verkaufen

Handeln Handeln

281,55 EUR -2,05 EUR -0,72 %

15:54:30

FSE

263,40 CHF -1,30 CHF -0,49 %

16:07:20

SWX

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handeln Smartphone

Marktkap.225,30 Mrd. EUR

KGV24,60Div. Rendite3,80%

WKN855167

ISINCH0012032048

SymbolRHHVF

Roche Aktien News

Sortieren:Datum Meistgelesen

07:00Roche Holding AGRoche’s Tecentriq combined with lurbinectedin shows significant survival benefit in extensive-stage small cell lung cancer

31.05.25GlobeNewswireNew data show Roche’s Itovebi significantly extended survival in a certain type of HR-positive advanced breast cancer

31.05.25Roche Holding AGNew data show Roche’s Itovebi significantly extended survival in a certain type of HR-positive advanced breast cancer

WerbungRoche-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero

30.05.25Roche Holding AGRoche’s fenebrutinib maintains near-complete suppression of disease activity and disability progression for up to two years in people with relapsing multiple sclerosis

30.05.25GlobeNewswireRoche’s fenebrutinib maintains near-complete suppression of disease activity and disability progression for up to two years in people with relapsing multiple sclerosis

23.05.25GlobeNewswireCHMP recommends EU approval of Roche’s Itovebi for PIK3CA-mutated, ER-positive, HER2-negative, advanced breast cancer

23.05.25GlobeNewswireRoche announces new collaboration with Broad Clinical Labs to accelerate adoption of cutting-edge SBX sequencing technology

23.05.25Roche Holding AGRoche announces new collaboration with Broad Clinical Labs to accelerate adoption of cutting-edge SBX sequencing technology

23.05.25Roche Holding AGNew two-year follow-up of Roche’s Columvi extends overall survival in relapsed or refractory diffuse large B-cell lymphoma patients

23.05.25GlobeNewswireNew two-year follow-up of Roche’s Columvi extends overall survival in relapsed or refractory diffuse large B-cell lymphoma patients

22.05.25GlobeNewswireFDA approves Roche’s Susvimo for diabetic retinopathy

22.05.25Roche Holding AGFDA approves Roche’s Susvimo for diabetic retinopathy

20.05.25Roche Holding AGRoche provides update on FDA Advisory Committee meeting on Columvi combination for people with relapsed or refractory diffuse large B-cell lymphoma

20.05.25GlobeNewswireRoche provides update on FDA Advisory Committee meeting on Columvi combination for people with relapsed or refractory diffuse large B-cell lymphoma

14.05.25Roche Holding AGRoche receives FDA approval for the VENTANA MET (SP44) RxDx Assay as the first companion diagnostic to identify non-squamous non-small cell lung cancer patients eligible for treatment with Emrelis

14.05.25GlobeNewswireRoche receives FDA approval for the VENTANA MET (SP44) RxDx Assay as the first companion diagnostic to identify non-squamous non-small cell lung cancer patients eligible for treatment with Emrelis

13.05.25Roche Holding AGTen-year APHINITY data show Roche’s Perjeta-based regimen reduced the risk of death by 17% in people with HER2-positive early-stage breast cancer

13.05.25GlobeNewswireTen-year APHINITY data show Roche’s Perjeta-based regimen reduced the risk of death by 17% in people with HER2-positive early-stage breast cancer

12.05.25PR NewswireRoche announces $550 million investment to expand its Indianapolis diagnostics manufacturing hub

06.05.25Roche Holding AGRoche introduces innovative Elecsys PRO-C3 test to improve precision in evaluating liver fibrosis severity

06.05.25GlobeNewswireRoche introduces innovative Elecsys PRO-C3 test to improve precision in evaluating liver fibrosis severity

Roche News

Roche News: auf dieser Seite finden Sie alle Roche News und Nachrichten zur Roche Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Roche News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Roche News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.